Health: New drugs against clinical microbes 2

Health: New drugs against clinical microbes

Oldenburg
/ Berlin

According to the latest data from the Robert Koch Institute, drug-resistant germs are still on the rise in Germany. In this context, Oldenburg MP Stephan Albani, Health Research Rapporteur for the CDU / CSU parliamentary group, called for further action at the start of the Berlin National Medicines Initiative: to colonization. In 2017, there were another 2576 casualties, ”Albani said. At the end of September, the figures were already above the 2017 level.

Many times resistant

According to Albanis, 760 people died in 2018 after being infected or colonized with Acinetobacter. In the year before, there were 638. “We are seeing more and more antibiotic-resistant bacterial microbes. To me, this is a clear signal that 2017 was the time to launch our national drug initiative in the Bundestag, which will provide € 20 million by 2021 to set up a national research strategy to study multidrug-resistant bacteria. "Oldenburg-Ammerländer During 2016, a Bundestag scholar and member submitted a parliamentary proposal to disseminate drug discovery and develop an overall national antibiotic resistance strategy. It was adopted by the Bundestag in April 2017 and is part of a coalition agreement between the CDU / CSU and SPD.

Researcher results

At the Federal Network for Education and Research (BMBF) on October 8, the Helmholtz Center for Infection Research, the Fraunhofer Institute for Toxicology and Experimental Medicine, Charité University Medical Center and other university and pharmaceutical research institutions gave new results to their BMBF funded research projects. One of the goals of the overall national strategy is the development of new active substances, such as the so-called hospital germs. According to the German Society for Hospital Hygiene, approximately 30,000 patients, mostly impaired or freshly operated, suffer from aureus staphylococci in Germany alone. About a quarter of them die.